Meet PSI at the 12th KoNECT International Conference!
PSI CRO is attending KoNECT 2026 to meet with sponsors navigating the operational complexity of global phase 2–3 clinical trials across Asia-Pacific and beyond.
As the largest clinical trial conference in Asia, KoNECT brings together sponsors, regulators, investigators, and clinical research leaders focused on the future of drug development and trial execution. PSI, a Swiss-based global contract research organization operating in 58 countries, continues to expand its operational footprint across Asia-Pacific, including South Korea, where PSI has established a strong local presence since 2017.
Sponsors attending KoNECT can connect with PSI to discuss strategies for maintaining enrollment predictability, operational visibility, and high-quality data delivery in increasingly complex global programs. PSI supports sponsors with a 95% first-patient-in (FPI) on-time rate, 97% last-patient-in (LPI) on-time rate, and technology-enabled operational planning through its proprietary INTELIA™ platform.
Attending team members:
- Mina Kim
Senior Director, Business Development
Related resources:
Blog: The site economy: Understanding site decision-making
Webinar: Agentic AI in Clinical Trials — Swiss Biotech Day Panel
White Paper: The operational reality of agentic AI in phase 2-3 trials
